ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0411

Serial Vessel Wall Enhancement Change on High-Resolution MRI Vessel Wall Imaging in Primary Central Nervous System Vasculitis

Takashi Shimoyama1, Ken Uchino2, Leonard Calabrese2 and Rula Hajj-ali2, 1Nippon Medical School, Nippon, Japan, 2Cleveland Clinic, Cleveland, OH

Meeting: ACR Convergence 2020

Keywords: Imaging, Stroke, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: High-resolution vessel wall imaging (HR-VWI) is emerging as a tool of notable utility in the diagnosis of central nervous system vasculitis (CNS-V). However, little is known about monitoring the response to treatments in these patients. The aim of this study was to investigate the temporal vessel wall enhancement (VWE) pattern and its clinical practice through the management of patients with CNS-V

Methods: We extracted 9 patients with primary CNS-V who underwent serial high-resolution MRI vessel wall image (HR-VWI) from Cleveland Clinic prospective CNS vasculopathy registry. Visibility and VWE were analyzed in 17 intracranial artery segments (Bilateral ICA, M1, M2, A1, A2, P1, P2, VA, and BA). Intraluminal enhancement was classified into 3 categories (none, eccentric VWE, and concentric VWE).

Results: In unique 153 intracranial arterial segments, 39 arteries (25.5%) had concentric VWE on baseline HR-VWI. The frequencies of intracranial arteries with concentric VWE have decreased to 12.4% (19 of 153 arteries) at 1st follow-up image and 6.5% (10 of 153 arteries) at 2nd follow-up image, respectively (P< 0.001), [figure 1]. By contrast, the prevalence of intracranial arteries without VWE increased over time course (Baseline; 71.9% (110 of 153 arteries), 1st follow-up; 77.1% (118 of 153 arteries), and 2nd follow-up; 86.9% (133 of 153 arteries), P=0.004), [figure 2]. During the follow-up (mean follow-up 15.9 months), two patients had clinical flare-up at 1st follow-up image. New intraluminal enhancements were identified in 5 intracranial artery segments (Eccentric VWE: 0 to 2 arteries, Concentric VWE: 2 to 5 arteries). After intensive immunosuppressive treatment, VWE changes were improved at 2nd follow-up image (None: 27 to 31 arteries, Concentric VWE: 5 to 1 artery), [figure 3].

Conclusion: Decreasing contrast VWE at follow-up images were frequently observed in CNS-V patients after treatment.  Patients with flare-up had temporal VWE worsening during the clinical course. Serial vessel wall enhancement pattern on HR-VWI may be useful for monitoring the response to treatment in patients with CNS-V. Larger studies are needed to validate our observation.

Frequencies of intracranial arteries with concentric vessel wall enhancement (VWE)

Frequencies of intracranial arteries without any vessel wall enhancement (VWE)

Serial vessel wall enhancement (VWE) changes over time


Disclosure: T. Shimoyama, None; K. Uchino, None; L. Calabrese, AbbVie, 1, 2, GlaxoSmithKline, 1, Bristol-Myers Squibb, 1, Genentech, 1, 2, Janssen, 1, 2, Novartis, 1, 2, Sanofi, 1, Horizon, 1, Crescendo, 1, Gilead, 1; R. Hajj-ali, ABBVIE, 1, Rockpoint, 1.

To cite this abstract in AMA style:

Shimoyama T, Uchino K, Calabrese L, Hajj-ali R. Serial Vessel Wall Enhancement Change on High-Resolution MRI Vessel Wall Imaging in Primary Central Nervous System Vasculitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/serial-vessel-wall-enhancement-change-on-high-resolution-mri-vessel-wall-imaging-in-primary-central-nervous-system-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serial-vessel-wall-enhancement-change-on-high-resolution-mri-vessel-wall-imaging-in-primary-central-nervous-system-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology